The MARS system is based on the next generation of x-ray detectors (Medipix3RX) developed in collaboration with CERNUniversity of CanterburyUniversity of Otago, and other partners. MBI has established itself as the world’s leading research and development group in spectral molecular imaging and to-date has delivered the world’s first commercial pre-clinical small bore spectral scanner.